Synthetic horsepox virus could lead to more effective smallpox vaccine
Synthetic technology breakthrough points to safer vaccines and targeted cancer treatments...
List view / Grid view
Drug discovery research is funded primarily by government and by philanthropic groups. Later development is funded mainly by pharmaceutical companies.
Synthetic technology breakthrough points to safer vaccines and targeted cancer treatments...
The National Institutes of Health is awarding $18.9 million towards research that aims to accelerate the use of genome sequencing in clinical care...
A new gene therapy that targets the heart and requires only one treatment session has been found safe for patients with coronary artery disease...
The European Research Council has announced its 2018 grant competitions with a total budget of around €1.86bn...
The Medical Research Council has formed partnerships with UCB and AstraZeneca, the deals will help speed translation of discovery research into potential therapies...
Researchers have found a pattern of genes which is characteristic of osteoarthritis and may be a step towards better treatments for this condition.
The government has announced new funding of up to £86 million for UK firms to develop medical breakthroughs.
University of Warwick researchers are to improve the lives of India's millions of psychosis sufferers.
In the gut of patients with heart failure, important groups of bacteria are found less frequently and the gut flora is not as diverse as in healthy individuals.
A new study conducted by an international team of lung cancer researchers have identified new genetic variants for lung cancer risk.
Cancer research at the University of Warwick has received a boost thanks to the former Lord Mayor of Coventry Cllr Lindsley Harvard.
Nemus Bioscience announced that THC derived from NB1111 achieved significant tissue concentrations in multiple compartments of the eye...
This latest funding round attracts two prominent new investors; Brian Kennedy and Sir Brian Souter.
University of Warwick expertise is contributing to a world-first £1.5million study aiming to tackle one of the biggest public health threats we face - antibiotic resistance.
The wealth of data produced by the European Commission's Joint Research Centre (JRC) is now available to external users.